Allie Dashow was preparing for graduating with her doctorate in clinical psychology when she learned she had the rare, risky ...

Proper skincare is important, but so too are the kinds of skincare products you use. These are some of the skincare products most likely to increase the risk of eye cancer.

Eye experts at Flinders University have released new global findings that reveal how a rare eye cancer first appears, offering vital insights that will help doctors diagnose the disease earlier and ...

Eye cancer often develops with few symptoms, including vision changes or a dark spot on the iris (colored part) of your eye. Regular eye exams can help you get a diagnosis sooner. Cancers of the eye ...

Six years ago, 66-year-old Ron White, a retired civilian airfield manager from Lacey, Washington, went to the optometrist for a routine appointment. There, his doctor noticed a tiny spot in the back ...

Ocular adnexal tumors are relatively rare but require unique diagnostic and treatment considerations given the functional importance of the eye and periocular structures and their unique metastatic ...

A novel clinical tool discovered to predict patients’ response to therapy. Scientists took patient cells, expanded them, and reinfused back into patient to target cancer. Adoptive T cell therapy ...

Why are clinical trials in radiation oncology important? If you or a loved one is going through treatment for cancer, you may have wondered about clinical trials. How do they benefit patients? How ...

Malignant and premalignant ocular surface tumors (OSTs) can be sight- and life-threatening, potentially leading to vision loss, cosmetic disfigurement, severe morbidity, and even death. Early ...

For people diagnosed with ocular melanomas, the only effective treatment for many years has been radiation therapy which destroys sight in the affected eye. This was Melody Burchett’s experience when ...

Ophthalmologists can detect alterations such as hypertension, diabetes, cardiac and hepatic pathology, and even tumors through clues in different parts of the ocular organs. The eye, an organ exposed ...

Foghorn Therapeutics isn’t having much luck with FHD-286. Only weeks after the FDA released a trial of the drug in two blood cancers from a clinical hold, the biotech has abandoned plans for the ...